Anhui Province to explore supplies two-vote system tax processing difficulty or increase.

Pharmaceutical Network October 21 - The province explores the two-vote system of supplies October 19, according to the Fuyang City Health Insurance Bureau, Anhui Provincial Health Insurance Bureau and other relevant departments issued "Anhui Province public medical institutions clinical commonly used drugs centralized band procurement negotiation bargaining implementation plan" (hereinafter referred to as the "Implementation Plan").
Implementation Programme shows that the supply of medicines should be guaranteed.
adhere to the "two-vote system" and encourage the "one-vote system".
pharmaceutical production enterprises as the first responsible person to ensure the quality and supply of drugs, can be directly distributed, but also entrusted with distribution capacity, good reputation of the business enterprise distribution.
addition to force majeed force, such as the emergence of enterprises do not supply according to the contract, can not guarantee quality and supply, etc. , will be included in the provincial and municipal pharmaceutical centralized procurement of bad records list.
addition to Anhui Province, Jilin Provincial Health Insurance Bureau recently issued the Jilin Province to control high-value medical supplies implementation program, emphasizing the need to strengthen circulation management.
actively explore the province's public medical institutions through the "two-vote system" and other ways to reduce the circulation of high-value medical supplies.
at the same time, high-value medical supplies-related enterprises and their practitioners in good faith management and practice into the credit management system, strengthen the record of dishonesty, publicity and early warning, strengthen performance management.
public medical institutions should establish a selection mechanism for the distribution of high-value medical supplies, standardize the management of purchase and sale contracts, and strictly complete the repayment in accordance with the contract.
In addition, on October 16, Shanghai Sunshine Procurement Pharmaceutical Network also released a message that 38 pharmaceutical circulation or production enterprises signed a "two-vote system" commitment, to Jiangsu Fosun Pharmaceutical Sales Co., Ltd. commitment, for example, requires strict compliance with the two-vote system provisions in the city's production and business activities.
the two-vote system, the difficulty of tax processing or the increase of the two-vote system have many effects on the pharmaceutical market, in addition to the changes in the circulation pattern, the sales costs and tax management of pharmaceutical enterprises have also had an important impact.
"China Market" journal has published an article analysis, the two-vote system makes pharmaceutical industry enterprises from the form of low-cost insaling to commission rebate insying method, can urge pharmaceutical enterprises to return part of the agency fees, to avoid irregularities, in this case, the financial managers of pharmaceutical industry enterprises are faced with how to regulate the reasonable handling of high opening difference costs of the work challenges.
"Tax Administration" journal also published "two-vote system" under the background of pharmaceutical enterprises sales cost tax management analysis" article shows that before the implementation of the two-vote system, the pharmaceutical industry sales model mainly uses low-cost shipping agent model, also known as multi-ticket system insulation mode, that is, the general agent low-cost purchase from pharmaceutical production enterprises, multi-level agents repeatedly invoiced in this mode, pharmaceutical agents have a very high autonomy, agents at all levels also increase prices, resulting in high prices after the arrival of drugs.
due to the complexity of the circulation link and the small size and quantity of agents in some regions, the management of special VAT invoices is more difficult, and the pharmaceutical industry has become a disaster area for falsely opening special VAT invoices.
After the implementation of the two-vote system, the pharmaceutical industry's tax processing difficulties may be further increased, because invoicing can only be carried out at the beginning and end of the drug circulation, resulting in the pharmaceutical industry from small enterprises in the middle and lower reaches back to upstream large enterprises, a large number of consulting management services, pharmaceutical technology consulting, information technology and other titles of third-party service enterprises appear, that is, the so-called contract sales organization (CSO).
stage, third-party service enterprises are mixed, resulting in pharmaceutical production enterprises facing regulatory risks and compliance risks.
These third-party service enterprises to pharmaceutical manufacturers to issue a large number of consulting fees, advertising fees, conference fees, promotional fees invoices, some of which are the actual business, but many did not actually happen.
Some consulting enterprises are very small in size, no relevant technical personnel, such enterprises for pharmaceutical enterprises ins <1>, the name of the funds to withdraw funds into third-party service enterprises, third-party service enterprises become pharmaceutical enterprises to withdraw funds in the gray area.
.